Getting a Head Start on Pain: Simple Changes to Your Pre-Procedure Workflow for Assessing Misuse and Diversion of Opioids

CMEO BriefCase

Premiere Date: Wednesday, September 2, 2020

This activity offers CE credit for:

  1. Dental


Credit Expiration Date: Thursday, September 2, 2021

Begin Activity Now

Faculty


Mani Saraghi, DMD, DADBA Mani Saraghi, DMD, DADBA 
Diplomate, American Dental Board of Anesthesiology
Director, Dental Anesthesiology Residency Program
Jacobi Medical Center
Assistant Professor of Dentistry
Albert Einstein College of Medicine
Bronx, NY

Statement of Need

An adolescent or young adult's first exposure to opioids often occurs following a third molar extraction, and even though 85%-90% of these patients find the experience unpleasant due to side effects, up to 15% are at risk for misuse, abuse, and addiction. To mitigate risk of opioid dependency it is imperative that dentists and oral surgeons are aware of the patients medical history, engage in pre- and postoperative discussions about pain and pain management expectations, discuss the risks and possible side effects of opioids, and balance compassionate care that manages suffering with safety.

Risk assessment tools such as the Opioid Risk Tool can be used as a complement to medical history, while checking the Prescription Drug Monitoring Program (PDMP) can determine whether a patient has had any aberrant prescription behaviors. This CME Outfitters BriefCase activity focuses on when to use validated tools to assess patients for risk of misuse and diversion of opioids as well as strategies for engaging patients in the management of their pain.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Assess patients for risk of misuse and diversion of opioids using a validated tool.

Financial Support

Supported by an educational grant from Johnson & Johnson, administered by Johnson & Johnson

Target Audience

Dentists and oral surgeons

Credit Information

Dental:
This course meets the Dental Board of California’s requirements for .5 units of continuing education.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Saraghi reports that she is a consultant to the New York State Department of Health as a subject matter expert in acute dental pain management, including opioids, for a project called, "Dental Opioid Prescribing Using Health Literacy Concepts, Acute Pain Management".

Evan Luberger (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

BC-010-090220-57